Agilent Technologies Names Patrick Kaltenbach, Jacob Thaysen Business Group Presidents; New Organization Designed to Support Customers, Growth

Company Announces Three Reporting Segments as of Q1 FY15

SANTA CLARA, Calif., Nov. 20, 2014

Agilent Technologies Inc. (NYSE: A) today announced it has named two new business presidents and realigned its businesses to better serve customers.

Patrick Kaltenbach has been named senior vice president, Agilent, and president of the Life Sciences and Applied Markets Group (LSAG) business unit, which combines the former Chemical Analysis Group and Life Sciences business. The combination will result in most of Agilent's instrumentation and software being in one organization to better serve analytical laboratories with similar needs.

Jacob Thaysen has been appointed senior vice president, Agilent, and president of the Diagnostics and Genomics Group (DGG). This new business unit combines the Diagnostics and Genomics businesses and will serve the needs of clinical laboratories.

Both appointments are effective immediately. Fred Strohmeier, who has been president of the Life Sciences and Diagnostics Group (LDG), has announced his retirement, planned for the second quarter of FY15. He will serve as an advisor to the company until that time.

"I would like to thank Fred for his more than 35 years of contributions to the company," said Mike McMullen, Agilent president, chief operating officer and CEO-elect. "Building on his years of experience in life sciences, Fred most recently provided superb leadership of Agilent's entry into diagnostics. I wish him the best in his retirement."

"The organization we're announcing today is about serving our customers with ease, efficiency and a single voice," McMullen added. "By combining our businesses around market needs, rather than technologies, we provide our customers with an easier, more direct way to get the products, software and services they need.

"I am excited about the addition of Patrick and Jacob as business presidents. They are both proven leaders with deep knowledge and exceptional customer insights across the range of our businesses. The formation of our high-caliber executive team marks another step toward positioning Agilent to deliver on its outstanding growth opportunities."

About Patrick Kaltenbach

As group president for LSAG, Kaltenbach is responsible for leading Agilent's life sciences and applied chemical markets business.

Kaltenbach was most recently Agilent vice president and general manager of the Life Sciences Products and Solutions organization, where he had responsibility for the strategic direction and development of all Agilent life science products.

Kaltenbach joined Agilent's predecessor, Hewlett-Packard Co., in 1991 as an R&D engineer in the Capillary Electrophoresis business. He has held various management positions within R&D and senior management roles over the years. Kaltenbach holds a degree in precision engineering from the Karlsruhe University of Applied Science in Germany.

About Jacob Thaysen

As group president of DGG, Thaysen is now responsible for the strategic direction and day-to-day management of Agilent's diagnostics and genomics business.

Thaysen was most recently vice president and general manager of Agilent's Diagnostics and Genomics business within LDG. He was responsible for its overall operation, including strategic direction, project management, sales, marketing and R&D.

Thaysen joined Agilent in 2012 as part of the Dako acquisition. He was corporate vice president of R&D at Dako, and prior to that a management consultant at Copenhagen Consulting Co. (now Quartz+Co.). Previously, he was a founding partner and chief technology officer of Cantion, a research and defense application development company.

He holds a Ph.D. in physics from the Technical University of Denmark.

Both Kaltenbach and Thaysen are based at Agilent's corporate offices in Santa Clara, California.

New Financial Reporting Segments

Starting in Q1 FY15, Agilent's reporting segments will be Life Sciences and Applied Markets (LSAG), Diagnostics and Genomics (DGG), and Agilent CrossLab Group (ACG). ACG, announced in September and headed by Mark Doak, includes services and consumables.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. Agilent generated revenues of $4.0 billion in fiscal 2014. The company employs about 12,000 people worldwide. Information about Agilent is available at

# # #


Michele Drake
+1 408 345 8396

Investor Contact:

Alicia Rodriguez
+1 408 345 8948